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The metabolic syndrome (MetSyn) is a condition characterized by the clustering of 
risk factors associated with cardiovascular disease (CVD) that afflicts 50 million 
Americans. A wealth of literature has demonstrated the prognostic, diagnostic, and 
interventional use of cardiopulmonary exercise testing (CPET) in individuals with chronic 
disease. However, there is limited information on how MetSyn may alter cardiopulmonary 
responses to exercise; thus, the purpose of this study is to identify whether 
cardiopulmonary variables derived from CPET are altered in MetSyn. MetSyn was 
defined using the NCEP definition which includes central obesity, elevated fasting plasma 
triglycerides, low high-density lipoprotein cholesterol, elevated fasting plasma glucose, 
hypertension, or pharmacologic treatment for diagnosed hypertension, 
hypertriglyceridemia, or low HDL-C. A cohort of 3,181 participants (1,714 men, 1,467 
women),  age 20 to 79 years (43.8±12 years) completed CPET and metabolic risk factor 
assessment between January 1, 1971 and November 1, 2020. Cardiopulmonary 
variables assessed included: cardiorespiratory fitness (CRF) defined as the maximum 
volume of oxygen uptake (VO2max), ventilatory threshold (VO2@ VT), oxygen uptake 
efficiency slope (OUES), the ratio of ventilation to VO2 at peak exercise (peak VE/VO2) 
and the VE/VCO2slope. VO2max, RERmax, HRmax, VO2@VT, OUESnorm, and peak VE/VO2  
were altered in the MetSyn (P<0.05). Logistic regression analysis revealed that VO2max, 
VO2 @VT, OUESnorm, and peak VE/VO2 were all predictive of MetSyn (P<0.05). 
Cardiopulmonary responses to exercise were altered in individuals with MetSyn and 
several variables were predictive of MetSyn. Thus, lower cardiopulmonary response may 
have prognostic utility for identifying individuals at high risk of developing MetSyn or in 
determining the MetSyn severity. 
 
